Background/Aims: The skin provides protection against chemical, physical, and biological stressors, yet the skin morphology changes over the course of life. These changes might affect the skin barrier function and facilitate the onset of age-related diseases. Since orally applied lactic acid bacteria ameliorate signs of aged and atopic skin, we investigated the effects of a topically applied Lactococcuslactis emulsion. Methods: In a blinded, randomized, vehicle-controlled trial, we studied topical Lactococcus effects both in vitro and in 20 healthy female volunteers. Commercially available reconstructed human epidermis (RHE) was treated for 4 days (once daily) and volar forearms were treated for 30 days (twice daily). Results:Lactococcus formulations improve the skin barrier in RHE as shown by increased filaggrin and human β-defensin-2 expression as well as by the 23% declined mean apparent permeability coefficients for caffeine. A reduction of 18% in transepidermal water loss confirms this effect in humans. Moreover, Lactococcus emulsion optimized skin hydration and surface pH. Skin irritation was not detected. Conclusions:Lactococcus emulsion improved the skin barrier function with good biocompatibility. Moreover, our study exemplifies the translational predictive capacity of testing on RHE with respect to Lactococcus emulsion.

1.
Blume-Peytavi
U
,
Kottner
J
,
Sterry
W
,
Hodin
MW
,
Griffiths
TW
,
Watson
RE
, et al
Age-associated skin conditions and diseases: current perspectives and future options
.
Gerontologist
.
2016
Apr
;
56
Suppl 2
:
S230
42
.
[PubMed]
0016-9013
2.
Wohlrab
J
,
Gabel
A
,
Wolfram
M
,
Grosse
I
,
Neubert
RH
,
Steinbach
SC
.
Age- and diabetes-related changes in the free fatty acid composition of the human stratum corneum
.
Skin Pharmacol Physiol
.
2018
;
31
(
6
):
283
91
.
[PubMed]
1660-5527
3.
Rinnerthaler
M
,
Duschl
J
,
Steinbacher
P
,
Salzmann
M
,
Bischof
J
,
Schuller
M
, et al
Age-related changes in the composition of the cornified envelope in human skin
.
Exp Dermatol
.
2013
May
;
22
(
5
):
329
35
.
[PubMed]
0906-6705
4.
Nakagawa
N
,
Sakai
S
,
Matsumoto
M
,
Yamada
K
,
Nagano
M
,
Yuki
T
, et al
Relationship between NMF (lactate and potassium) content and the physical properties of the stratum corneum in healthy subjects
.
J Invest Dermatol
.
2004
Mar
;
122
(
3
):
755
63
.
[PubMed]
0022-202X
5.
Luebberding
S
,
Krueger
N
,
Kerscher
M
.
Skin physiology in men and women: in vivo evaluation of 300 people including TEWL, SC hydration, sebum content and skin surface pH
.
Int J Cosmet Sci
.
2013
Oct
;
35
(
5
):
477
83
.
[PubMed]
0142-5463
6.
Hönzke
S
,
Wallmeyer
L
,
Ostrowski
A
,
Radbruch
M
,
Mundhenk
L
,
Schäfer-Korting
M
, et al
Influence of Th2 Cytokines on the cornified envelope, tight junction proteins, and β-defensins in filaggrin-deficient skin equivalents
.
J Invest Dermatol
.
2016
Mar
;
136
(
3
):
631
9
.
[PubMed]
0022-202X
7.
Ali
RS
,
Falconer
A
,
Ikram
M
,
Bissett
CE
,
Cerio
R
,
Quinn
AG
.
Expression of the peptide antibiotics human beta defensin-1 and human beta defensin-2 in normal human skin
.
J Invest Dermatol
.
2001
Jul
;
117
(
1
):
106
11
.
[PubMed]
0022-202X
8.
Lai
Y
,
Cogen
AL
,
Radek
KA
,
Park
HJ
,
Macleod
DT
,
Leichtle
A
, et al
Activation of TLR2 by a small molecule produced by Staphylococcus epidermidis increases antimicrobial defense against bacterial skin infections
.
J Invest Dermatol
.
2010
Sep
;
130
(
9
):
2211
21
.
[PubMed]
0022-202X
9.
Rizzo
A
,
Losacco
A
,
Carratelli
CR
.
Lactobacillus crispatus modulates epithelial cell defense against Candida albicans through Toll-like receptors 2 and 4, interleukin 8 and human β-defensins 2 and 3
.
Immunol Lett
.
2013
Nov-Dec
;
156
(
1-2
):
102
9
.
[PubMed]
0165-2478
10.
Ong
PY
,
Ohtake
T
,
Brandt
C
,
Strickland
I
,
Boguniewicz
M
,
Ganz
T
, et al
Endogenous antimicrobial peptides and skin infections in atopic dermatitis
.
N Engl J Med
.
2002
Oct
;
347
(
15
):
1151
60
.
[PubMed]
0028-4793
11.
Hill
C
,
Guarner
F
,
Reid
G
,
Gibson
GR
,
Merenstein
DJ
,
Pot
B
, et al
Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic
.
Nat Rev Gastroenterol Hepatol
.
2014
Aug
;
11
(
8
):
506
14
.
[PubMed]
1759-5045
12.
Fernández
L
,
Delgado
S
,
Herrero
H
,
Maldonado
A
,
Rodríguez
JM
.
The bacteriocin nisin, an effective agent for the treatment of staphylococcal mastitis during lactation
.
J Hum Lact
.
2008
Aug
;
24
(
3
):
311
6
.
[PubMed]
0890-3344
13.
Kimoto-Nira
H
,
Suzuki
C
,
Kobayashi
M
,
Sasaki
K
,
Kurisaki
J
,
Mizumachi
K
.
Anti-ageing effect of a lactococcal strain: analysis using senescence-accelerated mice
.
Br J Nutr
.
2007
Dec
;
98
(
6
):
1178
86
.
[PubMed]
0007-1145
14.
Kimoto-Nira
H
,
Aoki
R
,
Sasaki
K
,
Suzuki
C
,
Mizumachi
K
.
Oral intake of heat-killed cells of Lactococcus lactis strain H61 promotes skin health in women
.
J Nutr Sci
.
2012
Dec
;
1
:
e18
.
[PubMed]
2048-6790
15.
Ohta
K
,
Kawano
R
,
Ito
N
.
Lactic acid bacteria convert human fibroblasts to multipotent cells
.
PLoS One
.
2012
;
7
(
12
):
e51866
.
[PubMed]
1932-6203
16.
Lew
LC
,
Liong
MT
.
Bioactives from probiotics for dermal health: functions and benefits
.
J Appl Microbiol
.
2013
May
;
114
(
5
):
1241
53
.
[PubMed]
1364-5072
17.
Guéniche
A
,
Bastien
P
,
Ovigne
JM
,
Kermici
M
,
Courchay
G
,
Chevalier
V
, et al
Bifidobacterium longum lysate, a new ingredient for reactive skin
.
Exp Dermatol
.
2010
Aug
;
19
(
8
):
e1
8
.
[PubMed]
0906-6705
18.
van der Hoeven
H
,
Prade
H
.
An in vitro study of skin renewal with a probiotic anti-ageing agent
.
Household and Personal Care Today
.
2015
;
10
:
27
31
.
19.
Schäfer-Korting
M
,
Bock
U
,
Gamer
A
,
Haberland
A
,
Haltner-Ukomadu
E
,
Kaca
M
, et al
Reconstructed human epidermis for skin absorption testing: results of the German prevalidation study
.
Altern Lab Anim
.
2006
Jun
;
34
(
3
):
283
94
.
[PubMed]
0261-1929
20.
Netzlaff
F
,
Kaca
M
,
Bock
U
,
Haltner-Ukomadu
E
,
Meiers
P
,
Lehr
CM
, et al
Permeability of the reconstructed human epidermis model Episkin in comparison to various human skin preparations
.
Eur J Pharm Biopharm
.
2007
Apr
;
66
(
1
):
127
34
.
[PubMed]
0939-6411
21.
OECD 428: Test No. 428: skin absorption: in vitro method. OECD Publishing, 2004.
22.
OECD 439: Test No. 439: in vitro skin irritation: reconstructed human epidermis test method. OECD Publishing, 2013.
23.
Kandarova
H
,
Willoughby
JA
,
De Jong
WH
,
Letasiova
S
,
Milasova
T
,
Bachelor
MA
, et al
Pre-validation of an in vitro skin irritation test for medical devices using the reconstructed human tissue model EpiDerm™
.
Toxicol In Vitro
.
2018
Aug
;
50
:
407
17
.
[PubMed]
0887-2333
24.
du Plessis
J
,
Stefaniak
A
,
Eloff
F
,
John
S
,
Agner
T
,
Chou
TC
, et al
International guidelines for the in vivo assessment of skin properties in non-clinical settings: Part 2. transepidermal water loss and skin hydration
.
Skin Res Technol
.
2013
Aug
;
19
(
3
):
265
78
.
[PubMed]
0909-752X
25.
Agache
P
,
Humbert
P
.
Measuring the Skin
.
Basel, Switzerland
:
Springer International Publishing
;
2004
.
26.
Heinrich
U
,
Koop
U
,
Leneveu-Duchemin
MC
,
Osterrieder
K
,
Bielfeldt
S
,
Chkarnat
C
, et al
Multicentre comparison of skin hydration in terms of physical-, physiological- and product-dependent parameters by the capacitive method (Corneometer CM 825)
.
Int J Cosmet Sci
.
2003
Apr
;
25
(
1-2
):
45
53
.
[PubMed]
0142-5463
27.
Kelchen
MN
,
Menon
G
,
Ten Eyck
P
,
Prettypaul
D
,
Brogden
NK
.
A pilot study to evaluate the effects of topically applied cosmetic creams on epidermal responses
.
Skin Pharmacol Physiol
.
2018
;
31
(
5
):
269
82
.
[PubMed]
1660-5527
28.
Song
AA
,
In
LL
,
Lim
SH
,
Rahim
RA
.
A review on Lactococcus lactis: from food to factory
.
Microb Cell Fact
.
2017
Apr
;
16
(
1
):
55
.
[PubMed]
1475-2859
29.
Sandilands
A
,
Sutherland
C
,
Irvine
AD
,
McLean
WH
.
Filaggrin in the frontline: role in skin barrier function and disease
.
J Cell Sci
.
2009
May
;
122
(
Pt 9
):
1285
94
.
[PubMed]
0021-9533
30.
Richters
RJ
,
Falcone
D
,
Uzunbajakava
NE
,
Varghese
B
,
Caspers
PJ
,
Puppels
GJ
, et al
Sensitive skin: assessment of the skin barrier using confocal raman microspectroscopy
.
Skin Pharmacol Physiol
.
2017
;
30
(
1
):
1
12
.
[PubMed]
1660-5527
31.
Anderson
PC
,
Dinulos
JG
.
Are the new moisturizers more effective?
Curr Opin Pediatr
.
2009
Aug
;
21
(
4
):
486
90
.
[PubMed]
1040-8703
32.
Danby
SG
,
Brown
K
,
Higgs-Bayliss
T
,
Chittock
J
,
Albenali
L
,
Cork
MJ
.
The effect of an emollient containing urea, ceramide NP, and lactate on skin barrier structure and function in older people with dry skin
.
Skin Pharmacol Physiol
.
2016
;
29
(
3
):
135
47
.
[PubMed]
1660-5527
33.
Lodén
M
.
Effect of moisturizers on epidermal barrier function
.
Clin Dermatol
.
2012
May-Jun
;
30
(
3
):
286
96
.
[PubMed]
0738-081X
34.
Wirén
K
,
Nohlgård
C
,
Nyberg
F
,
Holm
L
,
Svensson
M
,
Johannesson
A
, et al
Treatment with a barrier-strengthening moisturizing cream delays relapse of atopic dermatitis: a prospective and randomized controlled clinical trial
.
J Eur Acad Dermatol Venereol
.
2009
Nov
;
23
(
11
):
1267
72
.
[PubMed]
0926-9959
35.
Augustin
M
,
Kirsten
N
,
Körber
A
,
Wilsmann-Theis
D
,
Itschert
G
,
Staubach-Renz
P
,
Maul
J-T
,
Zander
N
: Prevalence, predictors and comorbidity of dry skin in the general population. J Eur Acad Dermatol Venereol
2018
;0
36.
Vávrová
K
,
Henkes
D
,
Strüver
K
,
Sochorová
M
,
Školová
B
,
Witting
MY
, et al
Filaggrin deficiency leads to impaired lipid profile and altered acidification pathways in a 3D skin construct
.
J Invest Dermatol
.
2014
Mar
;
134
(
3
):
746
53
.
[PubMed]
0022-202X
37.
Korting
HC
,
Lukacs
A
,
Vogt
N
,
Urban
J
,
Ehret
W
,
Ruckdeschel
G
.
Influence of the pH-value on the growth of Staphylococcus epidermidis, Staphylococcus aureus and Propionibacterium acnes in continuous culture
.
Zentralbl Hyg Umweltmed
.
1992
Jun
;
193
(
1
):
78
90
.
[PubMed]
0934-8859
38.
Fluhr
JW
,
Elias
PM
.
Stratum corneum pH: formation and function of the ‘acid mantle’
.
Exog Dermatol
.
2002
;
1
(
4
):
163
75
.
39.
Takagi
Y
,
Kriehuber
E
,
Imokawa
G
,
Elias
PM
,
Holleran
WM
.
Beta-glucocerebrosidase activity in mammalian stratum corneum
.
J Lipid Res
.
1999
May
;
40
(
5
):
861
9
.
[PubMed]
0022-2275
40.
Holleran
WM
,
Takagi
Y
,
Uchida
Y
.
Epidermal sphingolipids: metabolism, function, and roles in skin disorders
.
FEBS Lett
.
2006
Oct
;
580
(
23
):
5456
66
.
[PubMed]
0014-5793
41.
Ali
N
,
Hosseini
M
,
Vainio
S
,
Taïeb
A
,
Cario-André
M
,
Rezvani
HR
.
Skin equivalents: skin from reconstructions as models to study skin development and diseases
.
Br J Dermatol
.
2015
Aug
;
173
(
2
):
391
403
.
[PubMed]
0007-0963
42.
Clausen
ML
,
Jungersted
JM
,
Andersen
PS
,
Slotved
HC
,
Krogfelt
KA
,
Agner
T
.
Human β-defensin-2 as a marker for disease severity and skin barrier properties in atopic dermatitis
.
Br J Dermatol
.
2013
Sep
;
169
(
3
):
587
93
.
[PubMed]
0007-0963
43.
Ahrens
K
,
Schunck
M
,
Podda
GF
,
Meingassner
J
,
Stuetz
A
,
Schröder
JM
, et al
Mechanical and metabolic injury to the skin barrier leads to increased expression of murine β-defensin-1, -3, and -14
.
J Invest Dermatol
.
2011
Feb
;
131
(
2
):
443
52
.
[PubMed]
0022-202X
44.
Vylkova
S
,
Nayyar
N
,
Li
W
,
Edgerton
M
.
Human β-defensins kill Candida albicans in an energy-dependent and salt-sensitive manner without causing membrane disruption
.
Antimicrob Agents Chemother
.
2007
Jan
;
51
(
1
):
154
61
.
[PubMed]
0066-4804
45.
Smietana
K
,
Siatkowski
M
,
Møller
M
.
Trends in clinical success rates
.
Nat Rev Drug Discov
.
2016
Jun
;
15
(
6
):
379
80
.
[PubMed]
1474-1776
46.
DiMasi
JA
,
Grabowski
HG
,
Hansen
RW
.
Innovation in the pharmaceutical industry: new estimates of R&D costs
.
J Health Econ
.
2016
May
;
47
:
20
33
.
[PubMed]
0167-6296
47.
Bailey
J
,
Thew
M
,
Balls
M
.
An analysis of the use of animal models in predicting human toxicology and drug safety
.
Altern Lab Anim
.
2014
Jun
;
42
(
3
):
181
99
.
[PubMed]
0261-1929
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.